BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 16952621)

  • 1. The influence of clinical and pathological stage discrepancy on cancer specific survival in patients treated for renal cell carcinoma.
    Svatek RS; Lotan Y; Herman MP; Duchene DA; Sagalowsky AI; Cadeddu JA
    J Urol; 2006 Oct; 176(4 Pt 1):1321-5; discussion 125. PubMed ID: 16952621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laparoscopic versus open partial nephrectomy for the treatment of pathological T1N0M0 renal cell carcinoma: a 5-year survival rate.
    Permpongkosol S; Bagga HS; Romero FR; Sroka M; Jarrett TW; Kavoussi LR
    J Urol; 2006 Nov; 176(5):1984-8; discussion 1988-9. PubMed ID: 17070227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
    Itano NB; Blute ML; Spotts B; Zincke H
    J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes following partial nephrectomy by tumor size.
    Crispen PL; Boorjian SA; Lohse CM; Sebo TS; Cheville JC; Blute ML; Leibovich BC
    J Urol; 2008 Nov; 180(5):1912-7. PubMed ID: 18801543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laparoscopic radical versus partial nephrectomy for tumors >4 cm: intermediate-term oncologic and functional outcomes.
    Simmons MN; Weight CJ; Gill IS
    Urology; 2009 May; 73(5):1077-82. PubMed ID: 19394509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
    Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H
    J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
    Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 7-year oncological outcomes after laparoscopic and open partial nephrectomy.
    Lane BR; Gill IS
    J Urol; 2010 Feb; 183(2):473-9. PubMed ID: 20006866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic versus open radical nephrectomy for large renal tumors: a long-term prospective comparison.
    Hemal AK; Kumar A; Kumar R; Wadhwa P; Seth A; Gupta NP
    J Urol; 2007 Mar; 177(3):862-6. PubMed ID: 17296361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of clinicopathological parameters in patients treated for renal cell carcinoma.
    Dall'Oglio MF; Arap MA; Antunes AA; Cury J; Leite KR; Srougi M
    J Urol; 2007 May; 177(5):1687-91. PubMed ID: 17437783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of tumour size in patients after tumour nephrectomy for localised renal cell carcinoma.
    Steiner T; Knels R; Schubert J
    Eur Urol; 2004 Sep; 46(3):327-30. PubMed ID: 15306102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
    Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retroperitoneal laparoscopic partial nephrectomy: surgical experience and outcomes.
    Pyo P; Chen A; Grasso M
    J Urol; 2008 Oct; 180(4):1279-83. PubMed ID: 18707736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes.
    Parekh DJ; Cookson MS; Chapman W; Harrell F; Wells N; Chang SS; Smith JA
    J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reevaluation of TNM staging of renal cortical tumors: recurrence and survival for T1N0M0 and T3aN0M0 tumors are equivalent.
    Gilbert SM; Murphy AM; Katz AE; Goluboff ET; Sawczuk IS; Olsson CA; Benson MC; McKiernan JM
    Urology; 2006 Aug; 68(2):287-91. PubMed ID: 16904438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of the 1997 TNM classification of renal cell carcinoma.
    Javidan J; Stricker HJ; Tamboli P; Amin MB; Peabody JO; Deshpande A; Menon M; Amin MB
    J Urol; 1999 Oct; 162(4):1277-81. PubMed ID: 10492179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional and oncological outcomes of partial nephrectomy of solitary kidneys.
    La Rochelle J; Shuch B; Riggs S; Liang LJ; Saadat A; Kabbinavar F; Pantuck A; Belldegrun A
    J Urol; 2009 May; 181(5):2037-42; discussion 2043. PubMed ID: 19298974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simple enucleation for the treatment of renal cell carcinoma between 4 and 7 cm in greatest dimension: progression and long-term survival.
    Carini M; Minervini A; Lapini A; Masieri L; Serni S
    J Urol; 2006 Jun; 175(6):2022-6; discussion 2026. PubMed ID: 16697790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does stage T3a renal cell carcinoma embrace a homogeneous group of patients?
    Gofrit ON; Shapiro A; Pizov G; Landau EH; Katz R; Zorn KC; Pode D
    J Urol; 2007 May; 177(5):1682-6. PubMed ID: 17437782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.